ijms-logo

Journal Browser

Journal Browser

Applications of Mesenchymal Stem Cells in Neuroscience 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 2730

Special Issue Editors


E-Mail Website
Guest Editor
Department of Psychology and Milan Center for Neuroscience (NeuroMi), University of Milano - Bicocca, Milan, Italy
Interests: mesenchymal stem cells; extracellular vesicles; microvesicles; exosomes; Alzheimer’s disease; microglial cells; inflammation
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Institute of Neuroscience, CNR (National Research Council of Italy) c/o IRCCS Humanitas Mirasole S.p.A., via Manzoni 56, 20089 Rozzano, Milan, Italy
2. IRCCS Humanitas Clinical and Research Center, via Manzoni 56, 20089 Rozzano, Milan, Italy
Interests: neuroimmunological disorders; mesenchymal stem cells; extracellular vesicles; Alzheimer's disease; diabetes; stroke; inflammation; aptamers
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Multipotent mesenchymal stem cells (MSC) have recently become very popular in cell therapy applications due to their multifaceted properties. Initially exploited for non-neurological pathologies, they are now also being applied in neurosciences. It has emerged, in fact, that most neurological conditions would benefit from a treatment able to provide tissue repair (neuroprotection and neurorestoration) and immunomodulatory effects (immunosuppressive and anti-inflammatory actions) delivered exactly at the site where it is needed. Therefore, new strategies are being studied to target inflammation and possibly to promote intrinsic regeneration potential. Along these directions, MSC are emerging as an extremely attractive tool due to their ability to release a proactive secretome composed of soluble factors and/or extracellular vesicles. MSC offer practical advantages for clinical applications because they can be isolated from adults with minimally invasive procedures. Applications of MSC or their byproducts are now studied for the treatment of many neurological disorders, including neurodegenerative and traumatic conditions for which there is no ideal cure to date.

The purpose of this Special Issue is to provide an overview of the current status of MSC application in neurological conditions and to delineate the current foundations for possible future applications in this field.

Dr. Coco Silvia
Dr. Malosio Maria Luisa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mesenchymal stem cells
  • extracellular vesicles
  • microvesicles
  • exosomes
  • neurodegenerative diseases
  • neurological conditions 
  • inflammation 
  • cell therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

26 pages, 986 KiB  
Review
Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
by Santino Blando, Ivan Anchesi, Emanuela Mazzon and Agnese Gugliandolo
Int. J. Mol. Sci. 2022, 23(14), 7545; https://doi.org/10.3390/ijms23147545 - 7 Jul 2022
Cited by 7 | Viewed by 2356
Abstract
Spinal cord injury (SCI) is a worldwide highly crippling disease that can lead to the loss of motor and sensory neurons. Among the most promising therapies, there are new techniques of tissue engineering based on stem cells that promote neuronal regeneration. Among the [...] Read more.
Spinal cord injury (SCI) is a worldwide highly crippling disease that can lead to the loss of motor and sensory neurons. Among the most promising therapies, there are new techniques of tissue engineering based on stem cells that promote neuronal regeneration. Among the different types of stem cells, mesenchymal stem cells (MSCs) seem the most promising. Indeed, MSCs are able to release trophic factors and to differentiate into the cell types that can be found in the spinal cord. Currently, the most common procedure to insert cells in the lesion site is infusion. However, this causes a low rate of survival and engraftment in the lesion site. For these reasons, tissue engineering is focusing on bioresorbable scaffolds to help the cells to stay in situ. Scaffolds do not only have a passive role but become fundamental for the trophic support of cells and the promotion of neuroregeneration. More and more types of materials are being studied as scaffolds to decrease inflammation and increase the engraftment as well as the survival of the cells. Our review aims to highlight how the use of scaffolds made from biomaterials enriched with MSCs gives positive results in in vivo SCI models as well as the first evidence obtained in clinical trials. Full article
(This article belongs to the Special Issue Applications of Mesenchymal Stem Cells in Neuroscience 2.0)
Show Figures

Figure 1

Back to TopTop